The chain of care enabling tPA treatment in acute ischemic stroke: a comprehensive review of organisational models
Authors:
- Maarten M. H. LahrMLMaarten M. H. Lahr
- Durk-Jouke ZeeDZDurk-Jouke Zee
- 23 August 2012
- journal article
- review article
- Published by Springer Nature in Journal of Neurology
- Vol. 260 (4) , 960-968
Abstract
Protracted and partial implementation of treatment with intravenous tissue plasminogen activator (tPA) within 4.5 h after acute stroke onset results in potentially eligible patients not receiving optimal treatment. The goal of this study was to review the performance of various organisational models of acute stroke care delivery, and subsequent attempts to improve implementation of tPA treatment. Publications comprehensively reporting on organisational models to improve implementation of i.v. tPA treatment of acute ischemic stroke patients were selected. The efficacy of organisational models was assessed using process outcome measures: thrombolysis rates, time-dependent operational endpoints (time delays), functional outcomes: safety (rate of symptomatic intracranial hemorrhage, mortality rates) and clinical outcome at 90 days (modified Rankin Scale). Fifty-eight published studies assessing organisational models were identified. Four dominant models of acute stroke care delivery were discerned, i.e., primary and comprehensive stroke centres, telemedicine, and the mobile stroke unit. Performance reported for these models suggest a large variation in administration of thrombolytic therapy (0.7–30 %). Time delays and functional outcomes found varied considerably, just like safety and mortality (0.0–11.5 %, and 3.4–31.9 %, respectively). These findings suggest that improving organisational models for tPA treatment may improve acute stroke care. However, implementation may be hampered by regional variation in acute stroke care capacity, expertise, and a fragmented approach towards organising stroke care.Keywords
This publication has 85 references indexed in Scilit:
- Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisThe Lancet, 2012
- Organization of a United States County System for Comprehensive Acute Stroke CareStroke, 2012
- Efficacy of Telemedicine for Stroke: Pooled Analysis of the Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC) and STRokE DOC Arizona Telestroke TrialsTelemedicine and e-Health, 2012
- Outcome of the ‘Drip-and-Ship’ Paradigm among Patients with Acute Ischemic Stroke: Results of a Statewide StudyCerebrovascular Diseases Extra, 2012
- Is the Drip-and-Ship Approach to Delivering Thrombolysis for Acute Ischemic Stroke Safe?The Journal of Emergency Medicine, 2011
- Association Between Stroke Center Hospitalization for Acute Ischemic Stroke and MortalityJAMA, 2011
- Stroke Team Remote Evaluation Using a Digital Observation Camera in ArizonaStroke, 2010
- Remote Supervision of IV-tPA for Acute Ischemic Stroke by Telemedicine or Telephone Before Transfer to a Regional Stroke Center Is Feasible and SafeStroke, 2010
- A Comprehensive Review of Prehospital and In-Hospital Delay Times in Acute Stroke CareInternational Journal of Stroke, 2009
- Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective studyThe Lancet Neurology, 2008